151 related articles for article (PubMed ID: 19022422)
1. Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease.
Kovacsovics-Bankowski M; Streeter PR; Mauch KA; Frey MR; Raber A; van't Hof W; Deans R; Maziarz RT
Cell Immunol; 2009; 255(1-2):55-60. PubMed ID: 19022422
[TBL] [Abstract][Full Text] [Related]
2. Oct4-negative multipotent adult progenitor cells and mesenchymal stem cells as regulators of T-cell alloreactivity in mice.
Luyckx A; De Somer L; Jacobs S; Rutgeerts O; Lenaerts C; Roobrouck VD; Verfaillie CM; Waer M; Van Gool SW; Billiau AD
Immunol Lett; 2011 Jun; 137(1-2):78-81. PubMed ID: 21382417
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
[TBL] [Abstract][Full Text] [Related]
4. [Multipotent adult progenitor cells from human bone marrow differentiate into hepatocyte-like cells induced by co-culture with human hepatocyte line].
Jiang ZS; Gao Y; Mu N
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):414-8. PubMed ID: 17456385
[TBL] [Abstract][Full Text] [Related]
5. Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease.
Badillo AT; Peranteau WH; Heaton TE; Quinn C; Flake AW
Br J Haematol; 2008 Apr; 141(2):224-34. PubMed ID: 18318768
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
[TBL] [Abstract][Full Text] [Related]
7. In vitro methotrexate as a practical approach to selective allodepletion.
Sathe A; Ortega SB; Mundy DI; Collins RH; Karandikar NJ
Biol Blood Marrow Transplant; 2007 Jun; 13(6):644-54. PubMed ID: 17531774
[TBL] [Abstract][Full Text] [Related]
8. Isolation procedure and characterization of multipotent adult progenitor cells from rat bone marrow.
Subramanian K; Geraerts M; Pauwelyn KA; Park Y; Owens DJ; Muijtjens M; Ulloa-Montoya F; Jiang Y; Verfaillie CM; Hu WS
Methods Mol Biol; 2010; 636():55-78. PubMed ID: 20336516
[TBL] [Abstract][Full Text] [Related]
9. Rat marrow-derived multipotent adult progenitor cells differentiate into skin epidermal cells in vivo.
Ji KH; Xiong J; Fan LX; Hu KM; Liu HQ
J Dermatol; 2009 Jul; 36(7):403-9. PubMed ID: 19583688
[TBL] [Abstract][Full Text] [Related]
10. Pluripotency rush! Molecular cues for pluripotency, genetic reprogramming of adult stem cells, and widely multipotent adult cells.
Beltrami AP; Cesselli D; Beltrami CA
Pharmacol Ther; 2009 Oct; 124(1):23-30. PubMed ID: 19545589
[TBL] [Abstract][Full Text] [Related]
11. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
Wang XN; Haniffa MA; Holtick U; Collin MP; Jackson G; Hilkens CM; Holler E; Edinger M; Hoffmann P; Dickinson AM
Transplantation; 2009 Jul; 88(2):188-97. PubMed ID: 19623013
[TBL] [Abstract][Full Text] [Related]
13. Stem cells. Controversial marrow cells coming into their own?
Holden C
Science; 2007 Feb; 315(5813):760-1. PubMed ID: 17289957
[No Abstract] [Full Text] [Related]
14. Pre-clinical safety testing supporting clinical use of allogeneic multipotent adult progenitor cells.
Kovacsovics-Bankowski M; Mauch K; Raber A; Streeter PR; Deans RJ; Maziarz RT; Van't Hof W
Cytotherapy; 2008; 10(7):730-42. PubMed ID: 18985479
[TBL] [Abstract][Full Text] [Related]
15. Human multipotent adult progenitor cells are nonimmunogenic and exert potent immunomodulatory effects on alloreactive T-cell responses.
Jacobs SA; Pinxteren J; Roobrouck VD; Luyckx A; van't Hof W; Deans R; Verfaillie CM; Waer M; Billiau AD; Van Gool SW
Cell Transplant; 2013; 22(10):1915-28. PubMed ID: 23031260
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory properties of human periodontal ligament stem cells.
Wada N; Menicanin D; Shi S; Bartold PM; Gronthos S
J Cell Physiol; 2009 Jun; 219(3):667-76. PubMed ID: 19160415
[TBL] [Abstract][Full Text] [Related]
17. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
[TBL] [Abstract][Full Text] [Related]
18. Multipotent adult progenitor cells.
Sohni A; Verfaillie CM
Best Pract Res Clin Haematol; 2011 Mar; 24(1):3-11. PubMed ID: 21396588
[TBL] [Abstract][Full Text] [Related]
19. A role for mesenchymal stem cells in the control of graft-versus-host disease.
Cohen JL; Sudres M
Transplantation; 2009 May; 87(9 Suppl):S53-4. PubMed ID: 19424007
[TBL] [Abstract][Full Text] [Related]
20. Multipotent adult progenitor cells: their role in wound healing and the treatment of dermal wounds.
Herdrich BJ; Lind RC; Liechty KW
Cytotherapy; 2008; 10(6):543-50. PubMed ID: 18836914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
